AbCellera, a firm that levearges single-cell analysis technologies to discover and develop therapeutic antibodies, has named Andrew Booth as chief financial officer and Tryn Stimart as general counsel.
Booth joins AbCellera from Stemcell Technologies, where he held the roles of vice president of instrumentation, chief financial officer, and chief commercial officer. Prior to this he led mergers and acquisitions for GE Healthcare's Europe, Middle East, and Africa business and its global life sciences business.
Stimart joins AbCellera from law firm Gibbons PC, where he was a partner in the firm's New York office. Prior to this, he held positions as legal counsel at Finnegan LLP, Cooley LLP, and Womble Bond Dickinson LLP.